Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-296843
Filing Date
2022-12-02
Accepted
2022-12-02 06:01:56
Documents
2
Group Members
AMGEN SINGAPORE MANUFACTURING PTE. LTD.AMGEN TECHNOLOGY, LTDONYX PHARMACEUTICALS, INC.SAGA INVESTMENTS COOPERATIEF U.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G d247438dsc13g.htm SC 13G 92533
2 EX-99.1 d247438dex991.htm EX-99.1 7562
  Complete submission text file 0001193125-22-296843.txt   101977
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93833 | Film No.: 221440196
SIC: 2834 Pharmaceutical Preparations